All these four big biotech companies are considered to be the candidates that may acquire other smaller biotech companies. They have to spend either significant amount of cash or issue corporate bonds in order to acquire other companies.
Normally when M&A activities happens, the acquirer’s stock may go down and the acquiree’s stock may go up. Wall Street had already priced in the potential M&A activities. That’s why you see these four big biotech companies have lower PE (except CELG). In the meantime, many other biotech companies, which do not make money but are considered to be potential acquiree, have very high valuation.
恶哥知道这四大美人现在涨不动的原因吗?告诉你就是
所有跟帖:
•
是这个道理, 哥在想今天的SPX小时线到了关键的点位, 如需破发, 需要那指的互动和板块的引领
-此恶要吾持久-
♂
(298 bytes)
()
08/10/2015 postreply
17:51:01
•
Yes, you are correct. but this year,
-峨嵋郭襄02-
♀
(646 bytes)
()
08/10/2015 postreply
18:20:42
•
Really agree with you. However, I would be more than happy
-此恶要吾持久-
♂
(289 bytes)
()
08/10/2015 postreply
19:02:58
•
Yes, TA is
-峨嵋郭襄02-
♀
(211 bytes)
()
08/10/2015 postreply
19:23:37